IGF1 and major depressive disorder: The elevation of peripheral total IGF-1 concentrations and its decline after antidepressants` treatment were established in several studies in MDD patients (21–23), moreover, it was reported that only patients in remission had attenuated IGF-1 concentrations following treatment (21, 22).